230 related articles for article (PubMed ID: 23827404)
1. Cardiovascular risk factor control and adherence to recommended lifestyle and medical therapies in persons with coronary heart disease (from the National Health and Nutrition Examination Survey 2007-2010).
Tang L; Patao C; Chuang J; Wong ND
Am J Cardiol; 2013 Oct; 112(8):1126-32. PubMed ID: 23827404
[TBL] [Abstract][Full Text] [Related]
2. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries.
Kotseva K; Wood D; De Backer G; De Bacquer D; Pyörälä K; Keil U;
Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):121-37. PubMed ID: 19287307
[TBL] [Abstract][Full Text] [Related]
3. Secondary prevention and risk factor target achievement in a global, high-risk population with established coronary heart disease: baseline results from the STABILITY study.
Vedin O; Hagström E; Stewart R; Brown R; Krug-Gourley S; Davies R; Wallentin L; White H; Held C
Eur J Prev Cardiol; 2013 Aug; 20(4):678-85. PubMed ID: 22496275
[TBL] [Abstract][Full Text] [Related]
4. Preventable coronary heart disease events from control of cardiovascular risk factors in US adults with diabetes (projections from utilizing the UKPDS risk engine).
Wong ND; Patao C; Malik S; Iloeje U
Am J Cardiol; 2014 Apr; 113(8):1356-61. PubMed ID: 24581920
[TBL] [Abstract][Full Text] [Related]
5. Extent of control of cardiovascular risk factors and adherence to recommended therapies in US multiethnic adults with coronary heart disease: from a 2005-2006 national survey.
Vulic D; Lee BT; Dede J; Lopez VA; Wong ND
Am J Cardiovasc Drugs; 2010; 10(2):109-14. PubMed ID: 20334448
[TBL] [Abstract][Full Text] [Related]
6. Compliance with cardiovascular drug prevention measures in a general population: the Multidisciplinary Intervention in Primary Care (IMAP) study.
Lopez-Carmona D; Bernal-Lopez M; Mancera-Romero J; Jansen-Chaparro S; Portales-Fernandez I; Baca-Osorio AJ; Perez-Gonzalez R; Tinahones FJ; Gomez-Huelgas R
Eur J Prev Cardiol; 2012 Oct; 19(5):1074-81. PubMed ID: 21810843
[TBL] [Abstract][Full Text] [Related]
7. Assessing risk factors of coronary heart disease and its risk prediction among Korean adults: the 2001 Korea National Health and Nutrition Examination Survey.
Ko M; Kim MT; Nam JJ
Int J Cardiol; 2006 Jun; 110(2):184-90. PubMed ID: 16412525
[TBL] [Abstract][Full Text] [Related]
8. Vital signs: prevalence, treatment, and control of hypertension--United States, 1999-2002 and 2005-2008.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Feb; 60(4):103-8. PubMed ID: 21293325
[TBL] [Abstract][Full Text] [Related]
9. Abdominal obesity and the spectrum of global cardiometabolic risks in US adults.
Ghandehari H; Le V; Kamal-Bahl S; Bassin SL; Wong ND
Int J Obes (Lond); 2009 Feb; 33(2):239-48. PubMed ID: 19050677
[TBL] [Abstract][Full Text] [Related]
10. EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries.
Kotseva K; Wood D; De Bacquer D; De Backer G; Rydén L; Jennings C; Gyberg V; Amouyel P; Bruthans J; Castro Conde A; Cífková R; Deckers JW; De Sutter J; Dilic M; Dolzhenko M; Erglis A; Fras Z; Gaita D; Gotcheva N; Goudevenos J; Heuschmann P; Laucevicius A; Lehto S; Lovic D; Miličić D; Moore D; Nicolaides E; Oganov R; Pajak A; Pogosova N; Reiner Z; Stagmo M; Störk S; Tokgözoğlu L; Vulic D;
Eur J Prev Cardiol; 2016 Apr; 23(6):636-48. PubMed ID: 25687109
[TBL] [Abstract][Full Text] [Related]
11. [Health care quality: medication and prevention in patients with and without coronary heart disease].
Baberg HT; Yazar A; Brechmann T; Grewe P; Kugler J; De Zeeuw J; Bojara W; Lawo T; Mügge A
Med Klin (Munich); 2004 Jan; 99(1):1-6. PubMed ID: 14716479
[TBL] [Abstract][Full Text] [Related]
12. Vital signs: prevalence, treatment, and control of high levels of low-density lipoprotein cholesterol--United States, 1999-2002 and 2005-200.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Feb; 60(4):109-14. PubMed ID: 21293326
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of lipid abnormalities in the United States: the National Health and Nutrition Examination Survey 2003-2006.
Tóth PP; Potter D; Ming EE
J Clin Lipidol; 2012; 6(4):325-30. PubMed ID: 22836069
[TBL] [Abstract][Full Text] [Related]
14. Implications of cardiac risk and low-density lipoprotein cholesterol distributions in the United States for the diagnosis and treatment of dyslipidemia: data from National Health and Nutrition Examination Survey 1999 to 2002.
Keevil JG; Cullen MW; Gangnon R; McBride PE; Stein JH
Circulation; 2007 Mar; 115(11):1363-70. PubMed ID: 17353444
[TBL] [Abstract][Full Text] [Related]
15. Implementation of cardiovascular secondary prevention guidelines in clinical practice: a nationwide survey in Italy.
Perrone-Filardi P; Poli A; Ambrosio G; Proto C; Chimini C; Chiariello M
Nutr Metab Cardiovasc Dis; 2012 Feb; 22(2):149-53. PubMed ID: 20875948
[TBL] [Abstract][Full Text] [Related]
16. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme.
EUROASPIRE II Study Group
Eur Heart J; 2001 Apr; 22(7):554-72. PubMed ID: 11259143
[TBL] [Abstract][Full Text] [Related]
17. Potential effects of reclassifying CKD as a coronary heart disease risk equivalent in the US population.
Foster MC; Rawlings AM; Marrett E; Neff D; Grams ME; Kasiske BL; Willis K; Inker LA; Coresh J; Selvin E
Am J Kidney Dis; 2014 May; 63(5):753-60. PubMed ID: 24369751
[TBL] [Abstract][Full Text] [Related]
18. Major coronary risk factors and death from coronary heart disease: baseline and follow-up mortality data from the Second National Health and Nutrition Examination Survey (NHANES II).
Mensah GA; Brown DW; Croft JB; Greenlund KJ
Am J Prev Med; 2005 Dec; 29(5 Suppl 1):68-74. PubMed ID: 16389129
[TBL] [Abstract][Full Text] [Related]
19. Secondary prevention for acute coronary syndrome in rural South Australia: are drugs best? What about the rest?
Wachtel TM; Kucia AM; Greenhill JA
Rural Remote Health; 2008; 8(4):967. PubMed ID: 18855517
[TBL] [Abstract][Full Text] [Related]
20. Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia.
Sorensen SV; Frick KD; Wade A; Simko R; Burge R
Clin Ther; 2009 Apr; 31(4):862-79. PubMed ID: 19446159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
